The GIS distribution of BRCA1/2-deficient tumors for ER + BC was significantly different from the distribution for ovarian cancer, indicating that the GIS threshold used for ovarian cancer may not be appropriate for ER + BC. This evidence concerns the gene BRCA1 and breast cancer.